Switching to single-use bioreactors can have financial and performance benefits.
Pascal Gerkens, PhD
Advertisement
Pascal Gerkens, PhD, is an associate scientist at Viral Industrial Bulk, GSK Biologicals
Articles by Pascal Gerkens, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement